WHO Approves Second Vaccine for Mpox Amid Rising Cases
The World Health Organization (WHO) approved the emergency use of a vaccine against mpox developed by the Japanese pharmaceutical company KM Biologics. This is the second vaccine approved by the agency, according to AFP. The WHO has announced that it has granted authorization to include the LC16m8 vaccine on its Emergency Use List (EUL) to…